Flow cytometry evaluation of cell cycle arrest in A549 human non-small cell lung cancer cells and tumors following treatment with cell cycle inhibitors: A multifaceted approach to targeting cancer
April 29, 2024
Immunophenotyping Pig Immune Cells by Flow Cytometry
By Jennifer J. Stewart, PhD
The Thing About Theranostics…
The landscape of oncology drug development is rapidly evolving, with personalized medicine taking center stage. At the heart of this revolution is ...
American Association of Pharmaceutical Scientists (AAPS) Flow Cytometry Action Programming Committee
By Jennifer J. Stewart, PhD
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.